Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient
Laura M. Tobin, … , Andrew E. Hogan, Donal O’Shea
Laura M. Tobin, … , Andrew E. Hogan, Donal O’Shea
Published December 21, 2017
Citation Information: JCI Insight. 2017;2(24):e94939. https://doi.org/10.1172/jci.insight.94939.
View: Text | PDF
Research Article Immunology Metabolism

NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient

  • Text
  • PDF
Abstract

Childhood obesity is a major global concern, with over 50 million children now classified as obese. Obesity has been linked to the development of numerous chronic inflammatory diseases, including type 2 diabetes and multiple cancers. NK cells are a subset of innate effector cells, which play an important role in the regulation of adipose tissue and antitumor immunity. NK cells can spontaneously kill transformed cells and coordinate subsequent immune responses through their production of cytokines. We investigated the effect of obesity on NK cells in a cohort of obese children, compared to children with a healthy weight. We demonstrated a reduction in peripheral NK cell frequencies in childhood obesity and inverse correlations with body mass index and insulin resistance. Compared with NK cells from children with normal weight, we show increased NK cell activation and metabolism in obese children (PD-1, mTOR activation, ECAR, and mitochondrial ROS), along with a reduced capacity to respond to stimulus, ultimately leading to loss of function (proliferation and tumor lysis). Collectively we show that NK cells from obese children are activated, metabolically stressed, and losing the ability to perform their basic duties. Paired with the reduction in NK cell frequencies in childhood obesity, this suggests that the negative effect on antitumor immunity is present early in the life course of obesity and certainly many years before the development of overt malignancies.

Authors

Laura M. Tobin, Meenal Mavinkurve, Eirin Carolan, David Kinlen, Eoin C. O’Brien, Mark A. Little, David K. Finlay, Declan Cody, Andrew E. Hogan, Donal O’Shea

×

Figure 1

NK cell frequencies are reduced in childhood obesity.

Options: View larger image (or click on image) Download as PowerPoint
NK cell frequencies are reduced in childhood obesity.
(A) Representative...
(A) Representative dot plots showing NK cells from a lean and an obese child. (B) Scatter plot showing NK cell frequencies (as a percentage of total lymphocytes) in lean (n = 35) and obese (n = 35) childhood cohorts. (C) Scatter plot displaying absolute number of NK cells (CD56+ cells/μl of blood) in a cohort of lean and obese children (n = 10/cohort). (D) Scatter plot detailing the BMI Z score of the lean and obese cohorts, and (E) correlation plot showing the negative association between NK cell frequencies and BMI Z score (Pearson R = –0.465, P = 0.0002). (F) Scatter plot detailing the HOMA-IR score of the lean and obese childhood cohorts. (G) Scatter plots detailing the frequencies of NK cells in obese children separated according to HOMA-IR insulin-sensitive (<3.1) and insulin-resistant (>3.1) groups. Statistical comparisons using Student’s t test. **P ≤ 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts